TOKYO -- Clinical trials for a COVID-19 pill have kicked off across the world, as pharmaceutical companies work on a simpler and more affordable way to treat patients and help finally bring the pandemic under control.
Coronavirus
From Pfizer to Shionogi, drugmakers race for coronavirus pills
Oral treatments crucial to beating pandemic enter late-stage trials
Merck plans to apply for emergency use authorization of its molnupiravir antiviral pill in the U.S. by the end of 2021. (Photo courtesy of Merck) © Kyodo
Read Next
.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on Coronavirus
